VEGFA expression is inhibited by arsenic trioxide in HUVECs through the upregulation of Ets-2 and miRNA-126

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Ge, Hong Yan ^a   Han, Zhong Jing ^a,b   Tian, Pei ^a   Sun, Wen Jie ^a,c   Xue, Da Xi ^a   Bi, Yu ^a   Yang, Zhanghui ^a   Liu, Ping ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b Daqing Oil Field General Hospital   (China)

^c THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARSENIC TRIOXIDE; MICRORNA 126; RNA DERIVATIVE; TRANSCRIPTION FACTOR ETS 2; VASCULOTROPIN A; ETS2 PROTEIN, HUMAN; MICRORNA; MIRN126 MICRORNA, HUMAN; ORGANOARSENIC DERIVATIVE; OXIDE; VEGFA PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; DOWN REGULATION; DRUG MECHANISM; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IC50; PROTEIN EXPRESSION; UMBILICAL VEIN ENDOTHELIAL CELL; UPREGULATION; BIOSYNTHESIS; CELL MOTION; CELL SURVIVAL; DRUG EFFECTS;

APOPTOSIS; ARSENICALS; CELL MOVEMENT; CELL PROLIFERATION; CELL SURVIVAL; DOWN-REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICRORNAS; OXIDES; PROTO-ONCOGENE PROTEIN C-ETS-2; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84942912871     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0135795     Document Type: Article

References (33)

1. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev Drug Discov. 2007; 6:273-286. PMID: 17396134
2. Yu W, Chai H, Li Y, Zhao H, Xie X, Zheng H, et al. Increased expression of CYP4Z1 promotes tumor angiogenesis and growth in human breast cancer. Toxicol Appl Pharmacol. 2012; 264:73-83. doi: 10. 1016/j.taap.2012.07.019 PMID: 22841774
3. Yao Q, Lin Y, Li X, Shen X, Wang J, Tu C. Curcumin ameliorates intrahepatic angiogenesis and capillarization of the sinusoids in carbon tetrachloride-induced rat liver fibrosis. Toxicol Lett.2003; 222:72-82.
4. Carmeliet P. Angiogenesis in health and disease. Nat. med.2003; 9:653-660. PMID: 12778163
5. Griffioen AW, Damen CA, Mayo KH, Barendsz-Janson AF, Martinotti S, et al. Angiogenesis inhibitors overcome tumor induced endothelial cell anergy. Int J Cancer. 1999; 80: 315-319 PMID: 9935216
6. Kong HL, Crystal RG. Gene therapy strategies for tumor antiangiogenesis. J Natl Cancer Inst. 1998; 90: 273-286 PMID: 9486813
7. Wang Z, Humphries B, Xiao H, Jiang Y, Yang C. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway. Toxicol Appl Pharmacol. 2013; 271:20-9. doi: 10.1016/j.taap.2013.04.018 PMID: 23643801
8. Jing Y, Liu LZ, Jiang Y, Zhu Y, Guo NL, Barnett J, et al. Cadmium increases HIF-1 and VEGF expression through ROS, ERK, and AKT signaling pathways and induces malignant transformation of human bronchial epithelial cells. Toxicol Sci.2012; 125:10-9. doi: 10.1093/toxsci/kfr256 PMID: 21984483
9. Hirooka T, Yamamoto C, Yasutake A, Eto K, Kaji T. Expression of VEGF-related proteins in cultured human brain microvascular endothelial cells and pericytes after exposure to methylmercury. J Toxicol Sci.2013; 38:837-45. PMID: 24213003
10. Soignet SL, Maslak P, Wang ZG, Jhanwar S, Calleja E, Dardashti LJ, et al. Complete remission after treatment of acute promyelocytic leukemia with arsenic trioxide. N Engl J Med. 1998; 339:1341-8. PMID: 9801394
11. Shen ZX, Chen GQ, Ni JH, Li XS, Xiong SM, Qiu QY, et al. Use of arsenic trioxide (As2O3) in the treatment of acute promy-elocytic leukemia (APL), II: clinical efficacy and pharmacokinetics in relapsed patients. Blood. 1997; 89:3354-60. PMID: 9129042
12. Agis H, Weltermann A, Mitterbauer G, Thalhammer R, Edelhäuser M, Seewann HL, et al.Successful treatment with arsenic trioxide of a patient with ATRA-resistant relapse of acute promyelocytic leukemia. Ann Hematol.1999; 78:329-32. PMID: 10466445
13. Galimberti S, Papineschi F, Carmignani A, Testi R, Fazzi R, Petrini M. Arsenic and all-trans retinoic acid as induction therapy before autograft in a case of relapsed resistant secondary acute promyelocytic leukemia. Bone Marrow Transplant. 1999; 24:345. PMID: 10455379
14. Roboz GJ, Dias S, Lam G, Lane WJ, Soignet SL, Warrell RP Jr, et al. Arsenic trioxide induces doseand time-dependent apoptosis of endothelium and may exert an antileukemic effect via inhibition of angiogenesis. Blood. 2000; 96:1525-1530. PMID: 10942401
15. Xiao YF, Liu SX, Wu DD, Chen X, Ren LF. Inhibitory effect of arsenic trioxide on angiogenesis and expression of vascular endothelial growth factor in gastric cancer. World J Gastroenterol. 2006; 12: 5780-5786. PMID: 17007042
16. Xiao YF, Wu DD, Liu SX, Chen X, Ren LF. Effect of arsenic trioxide on vascular endothelial cell proliferation and expression of vascular endothelial growth factor receptors Flt-1 and KDR in gastric cancer in nude mice. World J Gastroenterol. 2007; 13: 6498-6505. PMID: 18161919
17. Soucy NV, Ihnat MA, Kamat CD, Hess L, Post MJ, Klei LR, et al.Arsenic stimulates angiogenesis and tumorigenesis in vivo. Toxicol Sci. 2003; 76:271-9. PMID: 12970581
18. Visone R, Croce CM. MiRNAs and cancer. Am J Pathol. 2009; 174:1131-1138. doi: 10.2353/ajpath. 2009.080794 PMID: 19264914
19. Wu L, Belasco JG. Let me count the ways: mechanisms of gene regulation by miRNAs and siRNAs. Mol Cell.2008; 29:1-7. doi: 10.1016/j.molcel.2007.12.010 PMID: 18206964
20. Latronico MV, Catalucci D, Condorelli G. Emerging role of MicroRNAs in cardiovascular biology. Circ. Circ Res. 2007; 101:1225-1236. PMID: 18063818
21. Van Rooij E, Olson EN. MicroRNAs: powerful new regulators of heart disease and provocative therapeutic targets. J Clin Invest. 2007; 117:2369-2376. PMID: 17786230
22. Parker LH, Schmidt M, Jin SW, Gray AM, Beis D, Pham T, et al.The endothelial-cell-derived secreted factor Egfl7 regulates vascular tube formation. Nature. 2004; 428:754-758. PMID: 15085134
23. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell. 2008; 15:272-284. doi: 10.1016/j.devcel.2008.07.008 PMID: 18694566
24. Oettgen P. Regulation of vascular inflammation and remodeling by ETS factors. Circ Res. 2006; 99:1159-1166. PMID: 17122446
25. Turner DP, Findlay VJ, Moussa O, Watson DK. Defining ETS transcription regulatory networks and their contribution to breast cancer progression. J Cell Biochem. 2007; 102:549-559. PMID: 17661355
26. Dejana E, Taddei A, Randi AM. Foxs and Ets in the transcriptional regulation of endothelial cell differentiation and angiogenesis. Biochim Biophys Acta. 2007; 1775:298-312. PMID: 17572301
27. Sato Y. Role of ETS family transcription factors in vascular development and angiogenesis. Cell Struct Funct. 2001; 26:19-24. PMID: 11345500
28. Harris Tamia A., Munekazu Yamakuchi, Maiko Kondo, Peter Oettgen, Lowenstein Charles J. Ets-1 and Ets-2 regulate the expression of miR-126 in endothelial cells. Arterioscler Thromb Vasc Biol.2010; 30: 1990-1997. doi: 10.1161/ATVBAHA.110.211706 PMID: 20671229
29. Deshpande RG, Khan MB, Genco CA. Invasion of Aortic and Heart Endothelial Cells by Porphyromonas gingivalis. Infect and Immun.1998; 66: 5337-5343.
30. Hamma-Kourbali Y, Starzec A, Vassy R, Martin A, Kraemer M, Perret G, et al. Carboxymethyl benzylamide dextran inhibits angiogenesis and growth of VEGF-overexpressing human epidermoid carcinoma xenograft in nude mice. Br J Cancer. 2003; 89: 215-221. PMID: 12838326
31. Lee S, Chen TT, Barber CL, Jordan MC, Murdock J, Desai S, et al. Autocrine VEGF signaling is required for vascular homeostasis. Cell. 2007; 130:691-703. PMID: 17719546
32. Sun Y, Bai Y, Zhang F, Wang Y, Guo Y, Guo L. miR-126 inhibits non-small cell lung cancer cells proliferation by targeting EGFL7. Biochem Biophys Res Commun.2009; 391:1483-1489. doi: 10.1016/j. bbrc.2009.12.098 PMID: 20034472
33. Liu B, Peng XC, Zheng XL, Wang J, Qin YW. MiR-126 restoration down-regulate VEGF and inhibit the growth of lung cancer cell lines in vitro and in vivo. Lung Cancer.2009; 66:169-75. doi: 10.1016/j. lungcan.2009.01.010 PMID: 19223090